Myocarditis and Pericarditis After Vaccination for COVID-19
JAMA - Journal of the American Medical Association, 2021 Two previously healthy males presented to the emergency symptoms with signs of pericarditis/myocarditis after being vaccinated with an mRNA vaccine for COVID‐19.
Blake Hudson +2 more
exaly +2 more sources
COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021 [PDF]
Osong Public Health and Research Perspectives, 2021 Objectives On February 26, 2021, coronavirus disease 2019 (COVID-19) vaccination was started for high-priority groups based on the recommendation of the Advisory Committee on Immunization Practices with 2 available COVID-19 vaccines (AstraZeneca and ...
Hyun-kyung Oh +6 more
doaj +1 more source
COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021 [PDF]
Osong Public Health and Research Perspectives, 2021 Objectives This study aimed to present data on reported adverse events following coronavirus disease 2019 (COVID-19) vaccination in Republic of Korea from February 26 to October 31, 2021, and to determine whether any significant patterns emerged from an ...
Insob Hwang +4 more
doaj +1 more source
Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea [PDF]
Epidemiology and Health, 2022 OBJECTIVES In Korea, a national coronavirus disease 2019 (COVID-19) vaccination program was implemented, including 4 vaccines against COVID-19. A text messaging-based survey, in addition to a passive adverse event reporting system, was launched to ...
Yunhyung Kwon +7 more
doaj +1 more source
Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years [PDF]
Osong Public Health and Research Perspectives, 2022 Objectives This study aimed to identify potential safety signals and adverse events following the primary Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccination series among children and adolescents aged 5 to 17 years in the Republic of Korea ...
Seontae Kim +5 more
doaj +1 more source
Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea [PDF]
Clinical and Experimental Pediatrics, 2023 As of June 2022, 5 coronavirus disease 2019 (COVID-19) vaccine brands have been used in Korea’s national immunization program. The Korea Disease Control and Prevention Agency has enhanced vaccine safety monitoring through a passive web-based reporting ...
Yeon-Kyeng Lee +10 more
doaj +1 more source
Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea [PDF]
Osong Public Health and Research Perspectives, 2022 Objectives This study aimed to disseminate information on coronavirus disease 2019 (COVID-19) vaccine safety among adolescents aged 12 to 17 years in the Republic of Korea.
Seontae Kim +4 more
doaj +1 more source
The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022 [PDF]
Osong Public Health and Research Perspectives, 2023 Objectives Age-specific information regarding myocarditis/pericarditis in adolescents following mRNA-based coronavirus disease 2019 (COVID-19) vaccination in Asia remains insufficient. This study investigated the incidence and clinical characteristics of
Ju-Young Sim +2 more
doaj +1 more source
The initial experience of COVID-19 vaccination from a tertiary care centre of India
Monaldi Archives for Chest Disease, 2021 To the Editor Drugs Controller General of India (DCGI) has approved the Bharat biotech vaccine against COVID-19, which is a locally manufactured inactivated vaccine named ''COVAXIN'' in collaboration with the Indian council of medical research (ICMR ...
RK Srivastava +2 more
doaj +1 more source
“Marginal keratitis following COVID 19 vaccination”
IDCases, 2022 Purpose: To describe a novel case of marginal keratitis following COVID 19 vaccination. Methods: Case report Results: A 68-year-old female received the Moderna COVID 19 vaccine.
Daniel A. Farrell +2 more
doaj +1 more source